pyridostigmine bromide has been researched along with methylprednisolone in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Engel, WK; Oliver, KL; Patten, BM | 1 |
Donnelly, RJ; Fabri, B; Florence, AM; Hayward, M; Laquaglia, MP | 1 |
Bau, V; Hain, B; Hanisch, F; Zierz, S | 1 |
Bassam, BA; Hamilton, WJ; Maertens, P; Saulat, B | 1 |
Chen, W; Chou, C; Lee, H; Su, K; Tsai, C | 1 |
Chen, SL; Liu, XY; Zhang, WX | 1 |
Cirillo, N; Gombos, F; Heulfe, I; Landi, C; Lanza, A; Stellavato, A | 1 |
Adamu, MD; Balarabe, SA; Jiya, N; Watila, MM | 1 |
Liu, C; Peng, J; Wang, X; Wu, L; Xie, L; Zheng, X | 1 |
11 other study(ies) available for pyridostigmine bromide and methylprednisolone
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Adverse interaction between steroid hormones and anticholinesterase drugs.
Topics: Action Potentials; Animals; Anura; Cholinesterase Inhibitors; Dexamethasone; Drug Interactions; Edrophonium; Estrogens, Conjugated (USP); Glucocorticoids; Hydrocortisone; Magnesium; Male; Methylprednisolone; Muscle Contraction; Muscles; Myasthenia Gravis; Neostigmine; Prednisolone; Prednisone; Pyridostigmine Bromide; Rats; Sciatic Nerve; Tubocurarine | 1974 |
Cervical thymectomy in the treatment of myasthenia gravis.
Topics: Adult; Aged; Evaluation Studies as Topic; Female; Humans; Male; Methylprednisolone; Middle Aged; Myasthenia Gravis; Neostigmine; Postoperative Period; Pyridostigmine Bromide; Retrospective Studies; Thymectomy | 1984 |
[Ocular involvement in MuSK antibody-positive myasthenia gravis].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female; Humans; Methylprednisolone; Middle Aged; Myasthenia Gravis; Prednisolone; Pyridostigmine Bromide; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic | 2006 |
Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Topics: Autoantibodies; Child; Child, Preschool; Cholinesterase Inhibitors; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Myasthenia Gravis; Neuromuscular Junction; Pyridostigmine Bromide; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Thymectomy; Treatment Outcome | 2007 |
Myasthenia gravis associated with lupus nephritis.
Topics: Cholinesterase Inhibitors; Fatal Outcome; Female; Genetic Predisposition to Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Pyridostigmine Bromide; Siblings; Thymectomy; Young Adult | 2008 |
[Integrated traditional Chinese and Western medicine in treating 31 cases of myasthenia gravis].
Topics: Adolescent; Adult; Aged; Child; Cholinesterase Inhibitors; Diagnosis, Differential; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Chinese Traditional; Methylprednisolone; Middle Aged; Myasthenia Gravis; Phytotherapy; Pyridostigmine Bromide; Young Adult | 2008 |
Serum of patients with oral pemphigus vulgaris impairs keratinocyte wound repair in vitro: a time-lapse study on the efficacy of methylprednisolone and pyridostigmine bromide.
Topics: Cell Line; Cholinergic Agonists; Desmoglein 3; Glucocorticoids; Humans; Keratinocytes; Methylprednisolone; Mouth Diseases; Pemphigus; Pyridostigmine Bromide; Wound Healing | 2009 |
Neuromyelitis optica and myasthenia gravis in a young Nigerian girl.
Topics: Adolescent; Anti-Inflammatory Agents; Autoantibodies; Cholinesterase Inhibitors; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Myasthenia Gravis; Neuromyelitis Optica; Nigeria; Paraparesis, Spastic; Pyridostigmine Bromide; Spinal Cord; Treatment Outcome | 2015 |
[Analysis for the effect of different regimens on ocular myasthenia gravis in children].
Topics: Child; Cholinesterase Inhibitors; Eye Diseases; Glucocorticoids; Humans; Methylprednisolone; Myasthenia Gravis; Prednisone; Pyridostigmine Bromide; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Treatment Outcome | 2017 |